We serve Ammonium molybdate CAS:13106-76-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Items of Analysis | Standard of Analysis | Test Results |
Appearance | White or light yellow crystalline powder | Conform |
(NH4)2Mo4O13.2H2O | ≥99.0% | 99.21% |
MoO3 | ≥84.0% | 84.22% |
Mo | ≥56% | 56.36% |
Si | ≤0.0006% | 0.0006% |
Mg | ≤0.0006% | 0.0006% |
K | ≤0.01% | 0.009% |
Pb | ≤0.0006% | 0.0006% |
Ni | ≤0.0003% | 0.0003% |
Ca | ≤0.0008% | 0.0008% |
Cu | ≤0.0003% | 0.0003% |
Al | ≤0.0006% | 0.0006% |
Fe | ≤0.0006% | 0.0006% |
Na | ≤0.001% | 0.001% |
Mn | ≤0.0003% | 0.0003% |
Conclusion | Conforms to Factory Standard |
Contact us for information like Ammonium molybdate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,AMMONIUM MOLYBDATE physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Ammonium molybdate Use and application,Ammonium molybdate technical grade,usp/ep/jp grade.
Related News: Taiwan previously participated as an observer at the World Health Assembly, the W.H.O.’s governing body. 5-(4-Fluoro-phenylsulfanylmethyl)-2,6-bis-trimethylsilanyloxy-pyrimidine-4-carboxylic acid ethyl ester manufacturer Taiwan previously participated as an observer at the World Health Assembly, the W.H.O.’s governing body. 3-(4-(1-methoxyfluoranthen-3-yl)naphthalen-1-yl)acenaphtho[1,2-k]fluoranthene supplier When using the raw materials, as an API manufacturer we produce API in the large reactor in our plant.2-(2,3-dihydro-4-pironyl)acetic acid vendor It is foreseeable that in the future, the capacity and output of bulk APIs in China will decrease, the supply-demand relationship will be balanced, and prices and profits will gradually return to a more reasonable range. The era of low prices in the past will be gone forever. Individual APIs Varieties may even lose their price competitive advantage and move abroad.Myelodysplastic syndromes (MDS) are conditions that can occur when the blood-forming cells in the bone marrow become dysfunctional and thus produce an inadequate number of circulating blood cells.